Source comparison
5-Amino-1MQ vs MOTS-c: Research Comparison
Primary Mechanism NNMT enzyme inhibition → preserves NAD+ and blocks adipogenesis AMPK activation → enhances mitochondrial oxidative capacity 5-Amino-1MQ is preventive (blocks fat storage); MOTS-c is corrective (improves fat utilization) Primary Research Conte
This comparison does not assign a generated winner or score.
- Primary Mechanism
- NNMT enzyme inhibition → preserves NAD+ and blocks adipogenesis
- AMPK activation → enhances mitochondrial oxidative capacity
- 5-Amino-1MQ is preventive (blocks fat storage); MOTS-c is corrective (improves fat utilization)
- Primary Research Context
- Obesity models, adipocyte differentiation studies, metabolic syndrome
- Mitochondrial dysfunction, aging-related insulin resistance, exercise performance
- Use 5-Amino-1MQ when fat mass reduction is the primary endpoint; MOTS-c when mitochondrial health or insulin sensitivity is the focus
- Dosing Frequency
- Daily subcutaneous injection required to maintain NNMT suppression
- 2–3 times weekly due to prolonged downstream signaling effects
- MOTS-c offers more flexible dosing schedules for chronic studies
- Half-Life
- 4–6 hours (rodent models)
- 2–4 hours, but AMPK activation persists 24–48 hours
- Despite similar clearance rates, MOTS-c's metabolic effects last longer per dose
- Storage Stability (Post-Reconstitution)
- 28 days at 2–8°C; highly pH-sensitive
- Up to 60 days at 2–8°C; oxidation-sensitive (cysteine residue)
- Both require refrigeration; MOTS-c degrades faster with air exposure, 5-Amino-1MQ degrades faster at improper pH
- Observed Fat Mass Reduction
- 30% reduction in visceral adipose tissue (diet-induced obesity models, UT Southwestern study)
- Prevents diet-induced obesity when given prophylactically; minimal effect on established fat mass
- 5-Amino-1MQ demonstrates superior fat loss in already-obese models; MOTS-c is more effective as preventive intervention
- Insulin Sensitivity Improvement
- Moderate improvement secondary to fat loss and NAD+ restoration
- 25–40% improvement independent of weight loss (Nature Medicine, aged mouse model)
- MOTS-c produces greater insulin sensitivity gains even without significant weight reduction